These previous and current findings, taken together, suggest that GM3 species act as TLR4‐selective endogenous modulators to induce receptor dimerization/ oligomerization, and consequently enhance signal transduction leading to chronic inflammation in metabolic disorders. The gene discussed is TLR4; the disease is metabolic disease.